Amgen buys Micromet for $1.2 billion
January 27, 2012Research and Development, Sales and Marketing Amgen. Micromet, blinatumomab
Amgen is to buy German biotech firm Micromet for $1.16 billion to broaden its mid-stage pipeline and consolidate its oncology …
AXON Communications appoints Tina Hahn as vice president
January 27, 2012Medical Communications AXON Communications, Tina Hahn
AXON Communications has announced the appointment of Dr Tina Hahn as vice president, based in Copenhagen, Denmark. In addition to …
Bristol-Myers Squibb elects Gerald Storch to board of directors
January 26, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing BMS, Gerald Storch
Bristol-Myers Squibb has announced that its board has elected Gerald Storch to serve as a member of the audit committee, …
Abbott strong as it prepares for spin-out
January 26, 2012Sales and Marketing Abbott, GAAP, Humira
Abbott enjoyed a strong 2011 thanks to Humira and emerging market growth, with overall worldwide sales rising by 4.1 per …
Rebif approved for early use in MS
January 26, 2012Sales and Marketing MS, Merck KGaA, Merck Serono, Rebif
The European Commission has approved an indication for multiple sclerosis treatment Rebif that treats early signs of the condition.This EC …
New Leg-Mounted Autoclaves for Designated Clean-rooms
January 26, 2012Manufacturing and Production
Availability of stand-off legs for Priorclave’s range of bench-top autoclaves brings significant advantages to designated CAT 3 application areas providing …
CRAs spend less time on site, more time travelling
January 25, 2012Research and Development CRAs, Clinical Research Associates, Tufts, clinical trials
A new study of how clinical research associates (CRAs) spend their time has produced some interesting and surprising results. The …
Cell-based assays to help speed toxicity studies
January 25, 2012Research and Development Qiagen, cell-based assays, drug discovery
Use of cell-based assay technology is set to grow rapidly over the next decade, helping to speed up drug discovery …
Roche launches $5.7 billion hostile bid for Illumina
January 25, 2012Research and Development, Sales and Marketing Diagnostics, Illumina, Roche
Roche has launched a hostile takeover bid for US diagnostics company Illumina. The Swiss manufacturer appears tired of waiting for …
Premier Research appoints Etienne Drouet as executive director, Oncology Europe
January 25, 2012Business Services, Research and Development, Sales and Marketing Etienne Drouet, Premier Research
Premier Research Group has announced the appointment of Etienne Drouet to the position of executive director, Oncology Europe.In this position, …
Gates urges investment in innovations for developing nations
January 25, 2012Research and Development AIDS, Bill Gates, Global Fund, TB, malaria
Bill Gates has called on global leaders to invest in innovations that are accelerating progress against poverty, or risk a …
Councils given £2.2 billion for public health
January 25, 2012Research and Development, Sales and Marketing Lansley, NHS, public health outcomes framework
The government’s new vision for public health has come under fire from observers worried that accountability for the strategy remains …
MHRA Inspections of CROs
January 24, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Audits, Wainwright Associates, inspectons
In accordance with the provisions of the new pharmacovigilance legislation, as per Directive 2010/84/EU, EU Competent Authorities may inspect the …
Moving towards milestones: the evolving pharma – biotech relationship
January 24, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Deals, Susan Aldridge, biotech, pharma
Big pharma is going through the greatest ever wave of patent expiries, while small biotechs are finding it hard to …
Richard Barker elected to Celgene’s board of directors
January 24, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing ABPI, Celgene, Richard Barker
Celgene, the biopharma firm specialising in cancer and inflammatory diseases, has elected Richard Barker to its board of directors. Dr …
Genzyme’s Framingham site cleared by FDA
January 24, 2012Manufacturing and Production FDA, Fabrazyme, Fabry, Genzyme
The FDA has cleared Genzyme to begin production of Fabrazyme at its new manufacturing site. The approval of the new …
Patheon gets bigger in softgels with Procaps alliance
January 24, 2012Manufacturing and Production Patheon, Procaps, manufacturing
Contract development and manufacturing organisation Patheon has stepped up its position in the market for pharmaceutical capsules with the signing …
Alnylam cuts workforce by a third
January 23, 2012Research and Development, Sales and Marketing Alnylam, Novartis, job cuts, rnai
Alnylam will cut 33% of its workforce this year as it looks to focus on developing its own products. The …
MPs to criticise NHS reforms
January 23, 2012Sales and Marketing Clegg, Dorrell, NHS reform, health bill
Reform of the NHS is risking its financial stability and the care of the elderly, according to MPs. The concerns …
Carbogen Amcis buys French CRO
January 23, 2012Manufacturing and Production Carbogen Amcis, Creapharm Parenterals
Swiss contract manufacturing organisation Carbogen Amcis has acquired a contract manufacturer based in France – Creapharm Parenterals – to bolster …
Latest content
ESTEVE CDMO adds $17.5m to Illinois expansion
Brenntag and dsm-firmenich expand biopharma vitamin partnership
